ACOG Alpha Cognition: Forvard P/S multiplikatori
Alpha Cognition global nevrologiya sektorini nishonga olgan holda, Altsgeymer kasalligi uchun innovatsion davolash usullarini ishlab chiqadi. Murakkab sertifikatsiya jarayoni va patentlar uning ishlanmalarini nusxalashdan himoya qiladi, kritik talab esa kompaniyaga narxlarni belgilash imkoniyatini saqlab qolish imkonini beradi. GURU.Markets tomonidan taqdim etilgan ushbu forward price-to-sales baholash grafigi bozor kutganlarining tebranishlarini vizuallashtiradi, bunda 9.30 yakuniy daraja belgisi vazifasini bajaradi.
alphacognition.com (ACOG) kompaniyasining tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Alpha Cognition|ACOG - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Alpha Cognition Inc.|ACOG - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Alpha Cognition Inc.|ACOG - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Alpha Cognition|Tezkor likvidlik koeffitsiyenti alphacognition.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ACOG - Sof foyda|Prognoz qilingan kelajakdagi foyda Alpha Cognition|ACOG - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati Alpha Cognition Inc.|ACOG - O‘sish sur’atiga tuzatilgan narx-foyda|EV/EBITDA multiplikatori Alpha Cognition Inc.|ACOG - Amortizatsiya ajratmalaridan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Alpha Cognition|ACOG - So'nggi 12 oy davomida bir aksiya uchun foyda|Choraklik EPS foyda o'sishi alphacognition.com|ACOG - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Alpha Cognition
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:ACOG (Alpha Cognition Corp)
Zunveyl dori vositasining noyob yetkazib berish usuli tufayli sezilarli narx belgilash imkoniyatiga ega bo'lgan Alpha Cognition (ACOG) uchun ushbu ko'rsatkich joriy bozor kapitalizatsiyasining kutilayotgan kelajakdagi savdo hajmi nisbatini aks ettiradi. Kelajakdagi daromad ko'paytiruvchisini tahlil qilish investorlarga choraklik hisobotlar oralig'ida biznes qiymatini samarali baholash imkonini beradi, bu esa kirish nuqtasini o'tkazib yuborish xavfini kamaytiradi va elastik bo'lmagan talab sharoitida kapitalni keskin pasayishlardan himoya qiladi.
Raqobatchilar tahlili
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|Neurocrine (NBIX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Regencell - Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati Axsome Corp (AXSM)|ACADIA Pharmaceuticals (ACAD) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati XENE|VKTX (Viking Therapeutics, Inc.) - Forvard P/S multiplikatori|Supernus Pharmaceuticals, Inc. (SUPN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori CPRX (Catalyst Pharmaceuticals Inc)|Narxning kutilayotgan daromadga nisbati DNLI|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati biohavenpharma.com (BHVN)|AMLX - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Trevi Therapeutics Inc|Praxis Medicines (PRAX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AVXL|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Prothena Corporation|Forvard P/S multiplikatori ALEC|Forvard narx/daromad multiplikatori Annexon Biosciences ANNX|Narxning prognoz qilingan daromadga nisbati Omeros OMER|Neurogene Therapeutics (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|AC Immune - Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati voyagertherapeutics.com (VYGR)|Neumora Therapeutics, Inc. (NMRA) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati SCLX|TVGN (Tevogen Bio Holdings, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Cognition Therapeutics Inc. CGTX|Forvard narx/daromad multiplikatori IKT (Inhibikase Therapeutics)|Forvard P/S multiplikatori cassavasciences.com (SAVA)|Narxning prognoz qilingan daromadga nisbati Assertio ASRT|Sotuvga nisbatan forvard narx COYA|VTGN - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ovid Therapeutics Inc.|ABOS: Forvard P/S multiplikatori|cervomed.com (CRVO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Ltd.|Narxning prognoz qilingan daromadga nisbati CLNN|Narxning prognoz qilingan daromadga nisbati PepGen Inc. (PEPG)|JUNS: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori RLMD (Relmada Therapeutics)|Sotuvga nisbatan forvard narx ANVS|Grace Tx - Forvard P/S multiplikatori|AIFF - Forvard P/S multiplikatori|KLTO (anewmeds.com) - Forvard narx/daromad multiplikatori|NeuroSense Therapeutics Ltd. - Sotuvga nisbatan forvard narx|RVPH (Reviva Pharmaceuticals) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori MetaVia, Inc. (MTVA)|Narxning prognoz qilingan daromadga nisbati NeurAxis (NRXS)|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori PASG (Passage Bio)|Prognoz narxning daromadga nisbati Neuphoria Therapeutics, Inc.|NERV - Narxning prognoz qilingan daromadga nisbati|ATHA (athira.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ADXN: Forvard P/S multiplikatori|ALZN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori CYCN|PTIX (Protagenic) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati cortigent.com|Narxning prognoz qilingan daromadga nisbati Avenue Therapeutics, Inc. ATXI|Brainstorm Cell Therapeutics Inc. (BCLI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|CARA - Narxning prognoz qilingan daromadga nisbati|CHRO (Chromocell) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ELYM: Forvard P/S multiplikatori|Intra-Cellular Therapies, Inc. (ITCI) - Forvard P/S multiplikatori|LBPH (Longboard Pharmaceuticals, Inc.) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Marinus Pharmaceuticals Inc (MRNS)|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NRBO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|Prognoz narxning daromadga nisbati synaptogen.com|TRVN - Narxning prognoz qilingan daromadga nisbati|VIGL (Vigil Neuroscience) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|WENA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Cerevel Corp (CERE)
